(Q42222507)

English

In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications.

scientific article published on 25 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Epstein–Barr virus

0 references

lymphoproliferative disorders

1 reference

based on heuristic

inferred from title

Blanca Gonzalez-Farre

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

author name string

Jordina Rovira

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Alexandra Valera

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Adriana Garcia-Herrera

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Maria Angeles Marcos

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Carla Sole

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Elena Gonzalvo

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Imma Ribera-Cortada

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Monica Araya

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Josep Lloreta

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Luis Colomo

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Armando Lopez-Guillermo

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Antonio Martinez

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Daniel Martinez

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1599-1611

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

https://scigraph.springernature.com/pub.10.1038/modpathol.2014.68

0 references

Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Lytic and latent EBV gene expression in transplant recipients with and without post-transplant lymphoproliferative disorder.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

The relevance of molecular diagnostics in the practice of surgical pathology.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Endoplasmic reticulum stress causes EBV lytic replication

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Identification of early antigen BZLF1/ZEBRA protein of Epstein-Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Epstein-Barr-virus infection and persistence: a B-cell marriage in sickness and in health

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Cell-killing by Epstein-barr virus: Analysis by colony inhibition procedure

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Regulation of the Epstein-Barr virus Zp promoter in B lymphocytes during reactivation from latency

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

EBV-associated lymphomas in adults

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Epstein-Barr virus: 40 years on

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Soluble factors produced by activated CD4+ T cells modulate EBV latency

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Predictive value of Epstein-Barr virus genome copy number and BZLF1 expression in blood lymphocytes of transplant recipients at risk for lymphoproliferative disease.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Redistribution of FOXP3-positive regulatory T cells from lymphoid tissues to peripheral blood in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Replication of Epstein-Barr virus primary infection in human tonsil tissue explants

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Latent and lytic Epstein-Barr virus replication strategies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Progress and problems in understanding and managing primary Epstein-Barr virus infections

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

21 January 2018

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-transplant lymphoproliferative disorders: a preventable complication of solid organ transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2014.68

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762547%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42222507&oldid=1636416931"